Levofloxacin Use in Pediatric Patients

Critical Issues with Levofloxacin Prescription

The American Academy of Pediatrics does not generally recommend levofloxacin for pediatric patients due to concerns about effects on bone and cartilage growth 1
The CDC recommends that fluoroquinolones, including levofloxacin, are not approved for long-term use in children and adolescents due to concerns about effects on bone and cartilage growth 2
For children ≥5 years old, the recommended dose is 10 mg/kg once daily, with a maximum of 750 mg, according to the American Academy of Pediatrics 1
At 48 kg body weight, a pediatric patient should receive approximately 480 mg once daily (10 mg/kg × 48 kg), not the standard adult dose of 500 mg, as per the FDA guidelines 1

Pediatric infectious diseases specialist consultation is suggested prior to use of fluoroquinolones in children, as recommended by the Journal of Microbiology, Immunology and Infection 3
Acceptable uses include specific situations like drug-resistant tuberculosis or inhalational anthrax post-exposure where benefits outweigh risks, according to the American Academy of Pediatrics 1
For tuberculosis in children >5 years, dosing is 10 mg/kg once daily with a maximum of 750 mg, as per the CDC guidelines 1

If levofloxacin is absolutely required for a pediatric patient after specialist consultation, the dose should be 10 mg/kg once daily, not 500 mg, as recommended by the American Academy of Pediatrics 1
Without knowing the specific infection being treated, standard age-appropriate antibiotics should be prioritized over fluoroquinolones, according to the American Academy of Pediatrics 1, 2
Reserve fluoroquinolones for complicated infections, treatment failures, or infections caused by resistant pathogens, as recommended by the CDC 1, 2